Detalles de la búsqueda
1.
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation.
Eur J Clin Pharmacol
; 80(4): 529-543, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38252170
2.
Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings.
J Emerg Med
; 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38825531
3.
Antimicrobial Activity of Ceftazidime-Avibactam and Comparators against Pathogens Harboring OXA-48 and AmpC Alone or in Combination with Other ß-Lactamases Collected from Phase 3 Clinical Trials and an International Surveillance Program.
Antimicrob Agents Chemother
; 66(3): e0198521, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35225651
4.
Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015049
5.
Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30670413
6.
Avibactam Pharmacokinetic/Pharmacodynamic Targets.
Antimicrob Agents Chemother
; 62(6)2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29610208
7.
Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 62(11)2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30061279
8.
Penetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects.
Antimicrob Agents Chemother
; 60(10): 5849-57, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27431215
9.
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections.
Antimicrob Agents Chemother
; 59(1): 372-80, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25367904
10.
Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae.
Antimicrob Agents Chemother
; 58(2): 885-91, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24277021
11.
Real-world utilization of ceftazidime/avibactam among inpatients in the national Veterans Affairs Healthcare System.
Am J Health Syst Pharm
; 81(12): 509-520, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365226
12.
Evaluation of the effect of a supratherapeutic dose of intravenous ceftaroline fosamil on the corrected QT interval.
Antimicrob Agents Chemother
; 57(4): 1777-83, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23357764
13.
Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects.
Antimicrob Agents Chemother
; 57(3): 1496-504, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23295928
14.
Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia.
Antimicrob Agents Chemother
; 57(12): 6348-50, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041902
15.
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients.
Pediatr Infect Dis J
; 42(2): 99-105, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638392
16.
Population Pharmacokinetic Modeling for Ceftazidime-Avibactam Renal Dose Adjustments in Pediatric Patients 3 months and Older.
Clin Pharmacol Ther
; 113(1): 182-195, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36239478
17.
Real-world in vitro activity of newer antibiotics against Enterobacterales and Pseudomonas aeruginosa, including carbapenem-non-susceptible and multidrug-resistant isolates: a multicenter analysis.
Microbiol Spectr
; 11(6): e0312923, 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37937985
18.
Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study.
J Child Adolesc Psychopharmacol
; 33(6): 232-242, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37437109
19.
The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections.
Pediatr Infect Dis J
; 42(3): 199-205, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36476623
20.
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients With Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical Trials.
Open Forum Infect Dis
; 10(6): ofad256, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37305839